Merck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

This study is testing an oral drug called pimicotinib in Japanese patients with a rare, non-cancerous joint tumor called tenosynovial giant cell tumor (TGCT). The main goals are to see how well the drug is tolerated, how it moves through the body, and whether it can shrink the tu…

This is the first human study of an experimental cancer drug called M7437, which targets a specific protein found on certain tumor cells. The study will test the safety, side effects, and early effectiveness of M7437 in 138 people with advanced solid tumors that have stopped resp…